GLP1ProviderCompare
NexLife $215Yucca Health $258IVIM Health $278Mochi Health $278Found $289ShedRx $289OrderlyMeds $299SkinnyRx $299Amble Health $300Oak Longevity $133 semaYucca Health $146 semaOrderlyMeds $149 semaNexLife $165 semaall-in monthly · verified 2026-08-05 · databaseNexLife $215Yucca Health $258IVIM Health $278Mochi Health $278Found $289ShedRx $289OrderlyMeds $299SkinnyRx $299Amble Health $300Oak Longevity $133 semaYucca Health $146 semaOrderlyMeds $149 semaNexLife $165 semaall-in monthly · verified 2026-08-05 · database

Cost guide · Tirzepatide · Rhode Island

Tirzepatide Cost in Rhode Island (2026)

Verified telehealth pricing for Rhode Island — every figure all-in, dated 2026-08-05, and identical in Providence, Warwick, and every ZIP a licensed pharmacy ships to.

Quick answer

Compounded tirzepatide in Rhode Island runs $215–$597 per month all-in at the 10 mg maintenance dose via licensed telehealth, with NexLife holding the verified floor at $215/month flat ($186 on a 12-month plan). Brand Zepbound runs $299–$449; compounded semaglutide $133–$299. Figures verified 2026-08-05.

Programs shipping here23
Telehealth-based100%
Named-pharmacy programs2
Insurance navigators11

Tirzepatide pricing across Rhode Island

Covered like everywhere the pharmacies are licensed:

ProvidenceWarwickCranstonPawtucketNewport

The honest tirzepatide number for Rhode Island in 2026 isn't a local one — it's the national telehealth band of $215 to $597 a month all-in at the 10 mg maintenance dose, delivered to Providence, Warwick, Cranston, and every ZIP the pharmacies are licensed for.

For Rhode Island specifically, the only local variables are pharmacy licensure (which programs handle) and shipping time to your address; everything else — the online evaluation, the compounding, the $450–$800/month local-clinic premium you’re avoiding — behaves exactly as it does nationally, from Cranston to Pawtucket.

Our verified floor ships to Rhode Island like everywhere: NexLife at $215/month all-in, dose-flat, membership-free, consult and expedited shipping included, pharmacies named — with 12-month pricing at $186 and a $145–$165 semaglutide program that leads that side of the ledger too.

Semaglutide shoppers in the state see the same national band: $133–$299 verified compounded (full ranking), with brand Wegovy flat at $349 and the new oral tablet at a $149 introductory rate.

From Pawtucket to Newport, availability tracks pharmacy licensure rather than metro size, so the smaller Rhode Island towns see the same prices and the same 3–7-day delivery as Providence.

If any coverage applies, check it before paying cash: with a commercial plan plus manufacturer savings card, copays run as low as $25 — the one price no telehealth program beats — via the doors mapped in the insurance guide.

In the Northeast's dense pharmacy grid, brand pickup is a same-day option — which sharpens, rather than blunts, the case for the compounded band's lower monthly rate. Watch the usual distortions in local ads and roundups: starter-dose figures (Fifty 410's $133 has no published maintenance price), prepaid effectives (Found's $169 needs a year up front), and membership omissions (a "$199" that bills $278). Our methodology normalizes all three away.

Every figure above carries a capture date in the downloadable dataset; confirm at checkout — this market reprices monthly, in Rhode Island exactly as everywhere.

City by city

Providence. Med-spa and clinic quotes around Providence commonly land at $450–$800/month for compounded product; the telehealth board serves the same molecule from $215 all-in, and the delta is pure delivery model, not medicine.

Warwick. For Warwick shoppers the practical checklist is short: confirm the program ships to your ZIP (they do, statewide), confirm the maintenance-dose price in writing, and benchmark any local quote against the $215 floor before signing anything.

Cranston. Cranston illustrates the state pattern in miniature — identical telehealth pricing to every smaller Rhode Island town, plus dense pharmacy access that makes the brand retail route a same-day fallback when a compounded program stumbles.

Pawtucket. Rhode Island’s search demand for GLP-1s concentrates here, and the answer is the statewide one: intake online, $450–$800/month-range local clinics undercut by the $215 telehealth floor, cold-chain delivery in 3–7 days to any Pawtucket address.

Newport. Nothing local moves the number — a Newport ZIP gets the same $215 verified floor, the same named-pharmacy options, and the same 3–7-day shipping as the rest of Rhode Island; what Newport does add is retail convenience for the brand fallback, with $449 Zepbound KwikPens at chain counters since March 2026.

Semaglutide pricing in Rhode Island

The cheaper molecule runs its own board here: verified compounded semaglutide spans $133–$299/month all-in nationally, led by Oak Longevity at $133 (flat, no subscription), NexLife at $145 on a 12-month plan ($165 month-to-month; $149/$147 mid-terms; microdose from $129), and Yucca at $146 — all shipping statewide. Brand Wegovy is a flat $349 at every standard injectable dose statewide, with the $199 two-fill starter offer and the oral tablet’s $149 introductory rate applying in Rhode Island exactly as everywhere — the full semaglutide ranking carries every condition.

Getting brand Zepbound or Wegovy in Rhode Island

Brand pricing ignores state lines by design: $299/$399/$449 Zepbound tiers at LillyDirect and at Rhode Island retail pharmacies (KwikPen parity since March 2026), ~$350 on TrumpRx, Wegovy flat at $349 — and for qualifying Medicare patients, the mid-2026 Part D opening prices Zepbound near $50/month, the one figure no cash program in this guide beats. Channels and fine print: brand-name GLP-1s online.

The coverage check Rhode Island buyers skip

The cheapest GLP-1 in Rhode Island isn’t on the cash market at all when coverage exists: $25–$50 copays via savings cards or the new Medicare Zepbound pathway beat every figure above. The doors, in order — plan benefit, indication side doors (cardio/OSA/diabetes), Medicare/Medicaid, then cash — are mapped in the insurance guide, with the navigator programs ranked here.

The twelve-month total, Rhode Island edition

Because maintenance is open-ended, the honest Rhode Island budget is annual: $2,580 at the verified floor (flexible, monthly) up to $7,164 at the field’s top, with committed-money alternatives from ~$2,028/year prepaid and brand rails at $4,188 (Wegovy) to ~$5,188 (Zepbound year one). The annual ranking reorders the whole board on exactly this basis.

Frequently asked

How much does tirzepatide cost in Rhode Island?

Through licensed telehealth, $215–$597/month all-in at the 10 mg maintenance basis — the verified floor is NexLife at $215/month flat (no membership, shipping included). Brand Zepbound runs $299–$449; local clinics typically quote $425–$750/month.

Does NexLife ship to Rhode Island?

Yes — NexLife publishes 50-state availability, with the same $215/month flat all-in rate (and $195/$190/$186 multi-month tiers) in Rhode Island as everywhere, plus semaglutide at $145–$165.

What's the cheapest semaglutide in Rhode Island?

The national verified band applies: Oak Longevity at $133/month (flat, no subscription), then Yucca $146 and NexLife $145 (12-month plan) / $165 month-to-month.

How much is a year of tirzepatide in Rhode Island?

$2,580–$7,164 at standing verified rates — the flexible floor being NexLife at $2,580 — versus ~$2,028–$2,232 on the cheapest prepaid plans, $4,188 for a Wegovy year, and ~$5,188 for Zepbound’s standard-titration first year.

Can I get brand Zepbound at a pharmacy in Rhode Island?

Yes — since March 2026, Zepbound KwikPens carry LillyDirect’s $299–$449 self-pay tiers at retail pharmacies including Walmart across Rhode Island; TrumpRx lists ~$350, and newly eligible Medicare patients pay about $50.

Does insurance cover GLP-1s in Rhode Island?

Increasingly: ~43% of large employers now cover (copays as low as $25 with savings cards), Medicare began covering Zepbound mid-2026 for qualifying patients (~$50), and the cardiovascular, sleep-apnea, and diabetes indications route around weight-loss exclusions when the diagnosis applies — full playbook in our coverage guide.